SynthesisJournal of health, population, and nutrition2025
Prevalence of osteoporosis in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Synthesis in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Bone targeted microenvironment actuated engineered exosomes for precision therapy of IBD associated bone loss.Bioactive materials · 2026Article
- Treatable traits in inflammatory bowel disease: a conceptual framework for personalized care.EClinicalMedicine · 2026Review
- Exercise for Bone Mineral Density in People with Inflammatory Bowel Disease: A Systematic Review.Healthcare (Basel, Switzerland) · 2026Review
- Metabolic Disorders and Inflammatory Bowel Diseases: Unraveling Shared Pathways and Clinical Interactions.Metabolites · 2026Review
- Dietary potassium restriction causes hypercalciuria, hypocalcemia, and bone loss in male mice.JCI insight · 2026Article
- Prevalence of Comorbidities in Inflammatory Bowel Disease: An Umbrella Review of 18 Systematic Reviews.Journal of clinical medicine · 2026Review
- Nutrition phenotypes in inflammatory bowel disease: emerging concepts and future directions to guide clinical practice.Frontiers in nutrition · 2026Review
- Apoptosis-related genes bridge inflammatory bowel disease and osteoporosis: A bioinformatic analysis.PloS one · 2026Article
- Impact of biologic and targeted synthetic therapies on bone health in immune-mediated inflammatory diseases: a narrative review.Frontiers in medicine · 2026Review
- The brain-bone-gut axis: a microbial bridge underlying multisystem comorbidities.Frontiers in endocrinology · 2026Review
- The association between theFrontiers in genetics · 2026Article
- Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations.Journal of clinical medicine · 2025Review
- Long-Term Oral Budesonide Use in Inflammatory Bowel Disease: Effects on Bone Mineral Density and Late-Onset Adverse Events.Diagnostics (Basel, Switzerland) · 2025Article
- Tumor necrosis factor-alpha-mediated inflammatory bone loss: Pathogenic mechanisms and therapeutic potential of its inhibitors.Tzu chi medical journalReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough prior studies alluded to the association between inflammatory bowel disease (IBD) and osteoporosis, the exact prevalence of osteoporosis in this patient population remains variably reported. Therefore, we aimed to systematically explore the overall prevalence of osteoporosis in patients with IBD.
methodsWe searched in Embase, PubMed, and Scopus, from the inception until 31 May 2024. We included studies that reported cross-sectional data on the prevalence of osteoporosis in at least 100 adult (≥ 18 years) patients with IBD. We combined the data extracted from the eligible studies to obtain pooled estimates using a random-effects model.
resultsA total of 24 articles were included, comprising 417,298 patients with IBD. Our analysis showed that the overall pooled prevalence of osteoporosis in IBD patients was 12.2% (95% confidence interval [CI]: 9.1-15.3; I
conclusionThere is a significant prevalence of osteoporosis in patients with IBD, though variations by disease type and sex are not probably observed. We witnessed high heterogeneity among the studies. Tailored approaches are warranted for osteoporosis screening and management in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.